Monoclonal antibodies (mAbs) stimulate the immune system to mount a response to target antigens. In immunotherapy, scientists use mAbs to target various conditions, including cancer and autoimmune diseases. Despite technological and methodological advancements, researchers face challenges in mAb research. Therefore, they are developing optimized workflows to design, test, and produce mAbs efficiently and safely.
Download this infographic from Thermo Fisher Scientific to understand how researchers use mAbs to develop novel immunotherapies.